Sommario
La sindrome dell’ovaio policistico (PCOS) rappresenta la più comune patologia endocrina femminile, responsabile di infertilità, iperandrogenismo e sindrome metabolica. Manifestazioni tipiche includono oligo-amenorrea, irsutismo, acne e obesità e riscontro ecografico di policistosi ovarica a insorgenza in età puberale. La natura eterogenea e l’eziopatogenesi complessa pongono importanti difficoltà diagnostiche e controversie terapeutiche, specie nell’adolescente, che verranno prese in esame nel seguente articolo.
Bibliografia
Bremer AA (2010) Polycistic ovary syndrome in the pediatric population. Metab Syndr Relat Disord 8:375–394
Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group (2004) Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
Khan U (2007) Polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol 20:101–104
Warren-Ulanch J (2006) Treatment of PCOS in adolescence. Best Pract Res Clin Endocrinol Metab 20:311–330
Buggs C, Rosenfield RL (2005) Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 34:677–705
Yii MF, Lim CE, Luo X et al. (2009) Polycystic ovarian syndrome in adolescence. Gynecol Endocrinol 25:634–639
Blank SK, McCartney CR, Marshall JC (2006) The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Updat 12(4):351–361
Rosenfield L (2007) Identifying children at risk for polycistic ovary syndrome. J Clin Endocrinol Metab 92:787–796
Geller DH, Pacaud D, Gordon CM, Misra M (the Drug and Therapeutics Committee of the Pediatric Endocrine Society) (2011) State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS). Int J Pediatr Endocrinol 26:2011–2019
Pfeifer SM (2003) Polycystic ovary syndrome. J Pediatr Adolesc Gynecol 16:259–263
Carel JC, Eugster EA, Rogol A et al. (on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group) (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123:e752–e762
Hoeger K, Davidson K, Kochman L et al. (2008) The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 93:4299–4306
Conflitto di interessi
Gli autori Federica Guaraldi, Mirko Parasiliti Caprino, Pietro Pavarani, Lucia Ghizzoni dichiarano di non avere conflitti di interessi.
Consenso informato
L’articolo non contiene studi con sperimentazione umana effettuata dagli autori.
Studi sugli animali
L’articolo non contiene studi con sperimentazione animale effettuata dagli autori.
Author information
Authors and Affiliations
Corresponding author
Additional information
Proposta da Marco Boscaro.
Materiale elettronico supplementare
Rights and permissions
About this article
Cite this article
Guaraldi, F., Parasiliti Caprino, M., Pavarani, P. et al. La Sindrome dell’ovaio policistico nell’adolescente: quando e come diagnosticare, quando e come trattare. L'Endocrinologo 15, 1–8 (2014). https://doi.org/10.1007/s40619-014-0001-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-014-0001-5